期刊文献+

原发性乳房外Paget病组织中钠氢交换子调节因子1和β联蛋白的表达和意义 被引量:1

Expressions of N HERF1 and β-catenin in primary extramammary Paget's disease tissue and their significance
原文传递
导出
摘要 目的探讨钠氢交换子调节因子1(NHERF1)和β联蛋白在原发性乳房外Paget病组织中的表达及其意义。方法应用免疫组化方法,检测18例原位乳房外Paget病、22例侵袭性乳房外Paget病石蜡组织切片中NHERF1和β联蛋白的表达情况。结果NHERF1在22例侵袭性乳房外Paget病中18例(81.82%)为高表达,18例原位乳房外Paget病中7例(38.89%)高表达,两组差异有统计学意义(χ2=7.78,P〈0.01);β联蛋白在侵袭性乳房外Paget病中有0例胞膜高表达和18例(81.82%)胞质或核高表达,原位乳房外Paget病中分别为6例(33.33%)和8例(44.44%),两组差异均有统计学意义(χ2值分别为8.63和6.08,P值分别〈0.01和〈0.05)。原发性乳房外Paget病组织中NHERF1的表达与B联蛋白胞膜表达呈负相关(ρ=-0.488,P〈0.01),与β联蛋白胞质或核表达呈正相关(ρ=0.623,P〈0.01);β联蛋白胞膜表达与胞质或核表达呈负相关(ρ=-0.572,P〈0.01)。结论乳房外Paget病组织中NHERF1和β联蛋白表达异常,并可能与原发性乳房外Paget病的发生发展及侵袭有关。 Objective To investigate the expressions of Na+/H+ exchanger regulatory factor 1 (NHERF1) and β-catenin in extramammary Paget's disease tissue as well as their significance. Methods Immunohistochemistry was performed to detect the protein expressions of NHERF1 and β-catenin in paraffin-embeded tissue samples from 18 patients with in situ and 22 patients with invasive extramammary Paget's disease. Results There was a high expression of NHERF1 protein in 18 (81.82%) invasive and 7 (38.89%) in situ extramammary Paget's disease samples (χ2 = 7.78, P 〈 0.01). Statistical differences were observed in the membrane expression rate and cytoplasmic or nuclear expression rate of β-catenin between invasive and in situ extramammary Paget's disease tissue samples (0 (0/22) vs. 33.33% (6/18), χ2 = 8.63, P 〈 0.01; 81.82% (18/22) vs. 44.44% (8/18),χ2 = 6.08, P 〈 0.05). In extramammary Paget's disease in situ tissue samples, the expression of NHERF1 was negatively correlated with the cytomembrane expression of β-catenin (ρ = -0.488, P 〈 0.01 ), but positively correlated with the cytoplasmic or nuclear expression of β-catenin (ρ = 0.623, P 〈 0.01), and there was a negative correlation between the cytomembrane and cytoplasmic or nuclear expression of β-catenin (ρ = -0.572, P 〈 0.01). Conclusions There is an abnormal expression of NHERF1 and β-catenin in extramammary Paget's disease tissue, which may be associated with the initiation, progression, and invasion of primary extramammary Paget's disease.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2013年第8期561-564,共4页 Chinese Journal of Dermatology
基金 2011-2012年度北京协和医学院青年基金
关键词 佩吉特病 乳腺外β连环素 钠氢交换子调节因子1 Paget's disease, extramammary Beta catenin NHERF1
  • 相关文献

参考文献15

  • 1Giallourakis C, Cao Z, Green T, et al. A molecular-properties- based approach to understanding PDZ domain proteins and PDZ ligands. Genome Res, 2006, 16(8): 1056-1072.
  • 2Shibata T, Chuma M, Kokubu A, et al. EBP50, a beta-catenin- associating protein, enhances Wnt signaling and is over- expressed in hepatocellular carcinoma. Hepatology, 2003, 38 ( 1 ): 178-186.
  • 3Song J, Bai J, Yang W, et al. Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer. Histopathology, 2007, 51 ( 1 ): 40-53.
  • 4Hayashi Y, Molina JR, Hamilton SR, et al. NHERF1/EBP50 is a new marker in colorectal cancer. Neoplasia, 2010, 12( 12): 1013- 1022.
  • 5Molina JR, Morales FC, Hayashi Y, et al. Loss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivation. Cancer Res, 2010, 70 (17): 6697-6703.
  • 6Kikuchi A. Tumor formation by genetic mutations in the components of the Wnt signaling pathway. Cancer Sci, 2003, 94(3): 225-229.
  • 7Bienz M. 13-Catenin: A pivot between cell adhesion and Wnt signalling. Curr Biol, 2005, 15(2): R64-R67.
  • 8Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science, 2004, 303(5663): 1483-1487.
  • 9Taipale J, Beachy PA. The Hedgehog and Wnt signalling pathways in cancer. Nature, 2001, 411(6835): 349-354.
  • 10Fukumaru K, Yoshii N, Kanzaki T, et al. Immunohistochemical comparison of beta-catenin expression by human normal epidermis and epidermal tumors. J Dermatol, 2007, 34( 11 ): 746-753.

二级参考文献2

共引文献1

同被引文献16

  • 1Georgescu MM,Morales FC,Molina JR,et al.Roles of NHERFl/EBP50 in cancer.Curr Mol Med,2008,8(6):459-468.
  • 2Mamonova T,Kumikova M,Friedman PA.Structural basis forNHERFl PDZ domain binding.Biochemistry,2012,51(14):3110-3120.
  • 3Wheeler DS,Barrick SR,Grubisha MJ,et al.Direct interactionbetween NHERFl and Frizzled regulates β-catenin signaling.Oncogene,2011,30(1):32-42.
  • 4Neisch AL,Fehon RG.Ezrin,Radixin and Moesin:key regulatorsof membrane-cortex interactions and signaling.Curr Opin CellBiolj 2011,23(4):377-382.
  • 5Song J,Bai J,Yang W,et al.Expression and clinicopathologicalsignificance of oestrogen-responsive ezrin-radixin-moesin-bindingphosphoprotein 50 in breast cancer.Histopathology,2007,51(1):40-53.
  • 6Dai JL,Wang L,Sahin AA,et al.NHERF(Na+/H+ exchangerregulatory factor)gene mutations in human breast cancer.Onco-gene,2004,23(53):8681-8687.
  • 7Pan Y,Weinman EJ,Dai JL.NaVH+ exchanger regulatory factorI inhibits platelet-derived growth factor signaling in breast can-cer cells.Breast Cancer Res,2008,10(1):R5.
  • 8Cardone RA,Greco MR,Capulli M,et al.NHERFl acts as amolecular switch to program metastatic behavior and organ-otropism via its PDZ domains.Mol Biol Cell,2012,23(11):2028-2040.
  • 9Malfettone A,Saponaro C,Paradiso A,et al.Peritumoral vascularinvasion and NHERFl expression define an immunophenotype ofgrade 2 invasive breast cancer associated with poor prognosis.BMC Cancer,2012,12:106.
  • 10Malfettone A,Silvestris N,Paradiso A,et al.Overexpression ofnuclear NHERFl in advanced colorectal cancer:association withhypoxic microenvironment and tumor invasive phenotype.ExpMol Pathol,2012,92(3):296-303.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部